Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,832 | 95 | 99.5% |
| Gift | $17.24 | 1 | 0.4% |
| Education | $3.66 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bausch & Lomb Americas Inc. | $744.76 | 18 | $0 (2024) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $395.98 | 12 | $0 (2020) |
| ABBVIE INC. | $276.66 | 5 | $0 (2024) |
| Alcon Laboratories Inc | $240.93 | 6 | $0 (2018) |
| Alcon Vision LLC | $234.91 | 10 | $0 (2024) |
| CooperVision Inc. | $218.13 | 11 | $0 (2024) |
| Amgen Inc. | $188.63 | 2 | $0 (2024) |
| Sun Pharmaceutical Industries Inc. | $186.27 | 4 | $0 (2019) |
| Glaukos Corporation | $181.94 | 1 | $0 (2023) |
| Allergan, Inc. | $181.54 | 5 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $817.64 | 13 | Bausch & Lomb Americas Inc. ($342.74) |
| 2023 | $743.80 | 18 | Bausch & Lomb Americas Inc. ($233.80) |
| 2022 | $246.68 | 9 | Bausch & Lomb Americas Inc. ($168.22) |
| 2021 | $43.59 | 2 | Kala Pharmaceuticals, Inc. ($23.48) |
| 2020 | $136.26 | 6 | Novartis Pharmaceuticals Corporation ($61.55) |
| 2019 | $577.47 | 16 | Bausch & Lomb, a division of Bausch Health US, LLC ($196.49) |
| 2018 | $656.80 | 18 | Bausch & Lomb, a division of Bausch Health US, LLC ($183.35) |
| 2017 | $630.50 | 15 | Alcon Laboratories Inc ($227.83) |
All Payment Transactions
97 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/30/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Ophthalmology | ||||||
| 10/30/2024 | CooperVision Inc. | Clariti Contact Lens (Device) | Food and Beverage | In-kind items and services | $23.76 | General |
| Category: Devices | ||||||
| 08/19/2024 | Alcon Vision LLC | TOTAL30 (Device) | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: Ophthalmology | ||||||
| 07/31/2024 | Bausch & Lomb Americas Inc. | INFUSE (Device) | Food and Beverage | In-kind items and services | $137.50 | General |
| Category: Ophthalmology | ||||||
| 07/16/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Education | In-kind items and services | $3.66 | General |
| Category: Ophthalmology | ||||||
| 07/15/2024 | Bausch & Lomb Americas Inc. | INFUSE (Device) | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: Ophthalmology | ||||||
| 06/26/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug), MIEBO | Food and Beverage | In-kind items and services | $22.79 | General |
| Category: Ophthalmology | ||||||
| 06/18/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $120.65 | General |
| Category: Ophthalmology | ||||||
| 06/03/2024 | Bausch & Lomb Americas Inc. | INFUSE (Device) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: Ophthalmology | ||||||
| 05/21/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $121.13 | General |
| 04/03/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: Ophthalmology | ||||||
| 03/21/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $119.43 | General |
| Category: EYE CARE | ||||||
| 03/14/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $67.50 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/19/2023 | Bausch & Lomb Americas Inc. | INFUSE (Device) | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: Ophthalmology | ||||||
| 12/13/2023 | Alcon Vision LLC | Precision 1 (Device) | Food and Beverage | In-kind items and services | $66.88 | General |
| Category: Ophthalmology | ||||||
| 12/06/2023 | Bausch & Lomb Americas Inc. | MIEBO (Drug), VYZULTA | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: Ophthalmology | ||||||
| 11/28/2023 | AbbVie Inc. | LUMIGAN (Drug), ALPHAGAN P | Food and Beverage | In-kind items and services | $8.14 | General |
| Category: EYE CARE | ||||||
| 10/16/2023 | AbbVie Inc. | LUMIGAN (Drug), ALPHAGAN P | Food and Beverage | In-kind items and services | $9.56 | General |
| Category: EYE CARE | ||||||
| 10/10/2023 | Alcon Vision LLC | TOTAL30 (Device) | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: Ophthalmology | ||||||
| 08/31/2023 | CooperVision Inc. | MyDay Contact Lens (Device) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: Devices | ||||||
| 08/29/2023 | Glaukos Corporation | — | Food and Beverage | Cash or cash equivalent | $181.94 | General |
| 08/01/2023 | Bausch & Lomb Americas Inc. | INFUSE (Device) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: Ophthalmology | ||||||
| 07/21/2023 | Alcon Vision LLC | TOTAL30 (Device) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: Ophthalmology | ||||||
| 07/05/2023 | Bausch & Lomb Americas Inc. | ALDEN SCLERAL ZENLENS (Device) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: Ophthalmology | ||||||
| 06/21/2023 | Bausch & Lomb Americas Inc. | INFUSE (Device) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 305 | 361 | $35,750 | $18,006 |
| 2022 | 7 | 263 | 315 | $30,921 | $17,056 |
| 2021 | 7 | 250 | 284 | $26,994 | $13,539 |
| 2020 | 5 | 149 | 170 | $15,394 | $7,728 |
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 55 | 66 | $9,636 | $5,425 | 56.3% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 60 | 61 | $8,845 | $4,092 | 46.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 53 | 66 | $6,798 | $3,493 | 51.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 35 | 37 | $2,368 | $1,240 | 52.3% |
| 92134 | Imaging of retina | Office | 2023 | 36 | 47 | $2,491 | $1,069 | 42.9% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 21 | 26 | $1,924 | $996.60 | 51.8% |
| 92133 | Imaging of optic nerve | Office | 2023 | 32 | 44 | $2,288 | $934.59 | 40.8% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 13 | 14 | $1,400 | $756.30 | 54.0% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 64 | 65 | $9,425 | $4,957 | 52.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 43 | 51 | $7,446 | $4,658 | 62.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 42 | 53 | $5,459 | $3,234 | 59.2% |
| 92133 | Imaging of optic nerve | Office | 2022 | 37 | 53 | $2,756 | $1,275 | 46.3% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 22 | 29 | $2,146 | $1,210 | 56.4% |
| 92134 | Imaging of retina | Office | 2022 | 31 | 37 | $1,961 | $892.54 | 45.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 24 | 27 | $1,728 | $828.80 | 48.0% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 53 | 53 | $7,685 | $3,908 | 50.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 40 | 46 | $6,562 | $3,592 | 54.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 41 | 45 | $4,502 | $2,378 | 52.8% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 33 | 37 | $2,284 | $1,118 | 49.0% |
| 92083 | Measurement of field of vision during daylight conditions, extended examination | Office | 2021 | 20 | 26 | $1,924 | $941.83 | 49.0% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2021 | 33 | 44 | $2,288 | $906.87 | 39.6% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 30 | 33 | $1,749 | $695.02 | 39.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 58 | 61 | $7,564 | $3,843 | 50.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 40 | 50 | $4,200 | $2,435 | 58.0% |
| 99202 | New patient office or other outpatient visit, typically 20 minutes | Office | 2020 | 16 | 16 | $1,376 | $597.20 | 43.4% |
About Dr. Dawn Chivers, O.D
Dr. Dawn Chivers, O.D is a Optometrist healthcare provider based in Glens Falls, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1477558344.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dawn Chivers, O.D has received a total of $3,853 in payments from pharmaceutical and medical device companies, with $817.64 received in 2024. These payments were reported across 97 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($3,832).
As a Medicare-enrolled provider, Chivers has provided services to 967 Medicare beneficiaries, totaling 1,130 services with total Medicare billing of $56,328. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Practice Information
- Specialty Optometrist
- Location Glens Falls, NY
- Active Since 06/16/2005
- Last Updated 06/02/2011
- Taxonomy Code 152W00000X
- Entity Type Individual
- NPI Number 1477558344
Products in Payments
- INFUSE (Device) $536.65
- DAILIES (Device) $289.02
- XIIDRA (Drug) $214.97
- MIEBO (Drug) $161.63
- RESTASIS (Drug) $153.75
- LUMIGAN (Drug) $148.57
- CEQUA (Drug) $141.39
- BIOTRUE (Device) $141.14
- VUITY (Drug) $139.53
- VYZULTA (Drug) $136.15
- Izervay (Drug) $125.00
- Rhopressa (Drug) $116.71
- SIMBRINZA (Biological) $109.69
- Clariti Contact Lens (Device) $104.74
- LUXTURNA (Biological) $91.82
- TOTAL30 (Device) $85.50
- MyDay Contact Lens (Device) $82.04
- ULTRA (Device) $75.29
- Lucentis (Biological) $72.02
- TEPEZZA (Biological) $67.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Optometrist Doctors in Glens Falls
Dr. Carolee Boyd, O.d, O.D
Optometrist — Payments: $4,427
Dr. Paul Westfall, O.d, O.D
Optometrist — Payments: $1,857
Dr. Kamaljit Westfall, O.d, O.D
Optometrist — Payments: $1,631
Dr. Enrique Yepes-Hoyos, Od, OD
Optometrist — Payments: $1,358
Dr. Jeffrey Jarett, Od, OD
Optometrist — Payments: $495.71
Dr. Terry Walton, O.d, O.D
Optometrist — Payments: $342.79